Concord, MA · Founded 2020 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop an investigational siRNA medicine for preterm preeclampsia. Comanche Biopharma is based in Concord, MA and was founded in 2020. It was valued at $210 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $136 million across 2 recorded rounds; the latest was a $37.5 million early-stage round in Dec 2023.
These 8 firms already write checks for companies like Comanche Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.